advisorsecurities master

MYGNMyriad Genetics Inc

CSNasdaq (XNAS)·USD

Identity

Security key
18942
Ticker
MYGN
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
1995-10-06
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
MYGN

Detail

Enriched 2026-08-14 20:47

Market cap
$308,948,353.35
Shares outstanding (class)
95,649,645
Shares outstanding (weighted)
95,649,645
SIC
2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees
2,700
Location
SALT LAKE CITY, UT
Description

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data